Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
BioVie Inc. (BIVI) has been upgraded to a Zacks Rank #2 (Buy) due to its rising earnings estimates and improving business trend. The Zacks Rank stock-rating system effectively harnesses the power of earnings estimate revisions to classify stocks into five groups, ranging from Strong Buy to Strong Sell. The system has a proven track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.

Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios